Loading viewer...
report
Format: PDF report
This report discusses the efficacy of Lirentelimab (AK002) in treating Eosinophilic Esophagitis, highlighting its impact on dysphagia symptoms based on the ENIGMA study.
presentation
report
Marqeta
report
Talen Energy Supply
report
General Motors
report
888 Holdings plc